Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Kestra Medical Technologies (NASDAQ: KMTS) will present at the 44th Annual J.P.
Rhea-AI Summary
Kestra Medical Technologies (NASDAQ: KMTS) will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 2:15 p.m. PT.
Investors and interested parties can access a live webcast and replay via the company's investor relations website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – KMTS
On Dec 30, the day this news came out, KMTS closed 2.02% above the previous close.
Data tracked by StockTitan Argus for the Dec 30 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 13
- Conference presentation schedule
- Presentation time
- 2:15 p.m. Pacific Time
- Scheduled conference slot
Historical Context
-
Reported strong Q2 FY2026 growth and raised full-year revenue guidance.
-
Announced timing and access details for upcoming Q2 FY2026 results call.
-
Priced upsized public offering of 6,000,000 common shares at $23.00.
-
Proposed underwritten public offering of 5,500,000 shares with overallotment.
-
Preliminary Q2 results showed ~52% revenue growth and ~50% gross margin.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
wearable medical device medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 2:15 p.m. Pacific Time.
Interested parties may access the live webcast and replay of the presentation by visiting the Kestra Medical Technologies investor relations website.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.